Here are seven quick facts:
1. In the last few days, Jefferies Group has changed their ratings on a number of healthcare stock.
2. Christopher A. Holden, CEO of AmSurg, sold 3,000 shares of AmSurg stock on the open market in a transaction that occurred Wednesday.
3. The average price for the stock was sold at $69.02, totaling $207,060 for the entire transaction.
4. Shares of AmSurg went down 0.49 percent on Tuesday hitting a low of $68.76.
5. AmSurg has a market cap of $3.28 bullion and a price-to-earnings ratio of 59.38.
6. Analysts anticipate AmSurg will post $3.36 earnings per share for the current fiscal year.
7. Various other analysts have commented on the stock with Goldman Sachs analysts setting a buy rating and $81.00 price target on AmSurg stock.
For more ASC-related news:
Portsmouth Regional ASC files form D for $665k in financing
Dr. Black’s Eyes Associates opening dry eye center — 5 things to know
Dr. Henry Lee joins The Eye Care & Surgery Center in New Jersey
